Cleveland, MS24 Active Studies

Pulmonary Embolism Clinical Trials in Cleveland, MS

Find 24 actively recruiting pulmonary embolism clinical trials in Cleveland, MS. Connect with local research sites and explore new treatment options.

24
Active Trials
20
Sponsors
20,785
Enrolling

Recruiting Pulmonary Embolism Studies in Cleveland

About Pulmonary Embolism Clinical Trials in Cleveland

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 24 pulmonary embolism clinical trials recruiting participants in Cleveland, MS. These studies are seeking a combined 20,785 participants. Research is being sponsored by Centre hospitalier de l'Université de Montréal (CHUM), Potrero Medical, Weill Medical College of Cornell University and 17 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Cleveland — FAQ

Are there pulmonary embolism clinical trials in Cleveland?

Yes, there are 24 pulmonary embolism clinical trials currently recruiting in Cleveland, MS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cleveland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cleveland research site will contact you about next steps.

Are clinical trials in Cleveland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cleveland studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 24 active trials in Cleveland are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 13, 2026 from ClinicalTrials.gov